Experts call for safer weight loss as concerns grow over GLP-1 use
Japanese cases of ketosis and ketoacidosis are prompting a closer look at how GLP-1 medications, restrictive dieting, and…
Semaglutide dose may matter more than weight loss for heart health
A large real-world study suggests semaglutide’s cardiovascular benefits may be more closely linked to the dose patients receive…
People judge weight loss more harshly when GLP-1 drugs are involved, study finds
Even when medication is paired with diet and exercise, people may still feel their weight loss is less…
Genetic modification enhances “living drugs” for blood cancers
CAR T cells are patient-derived, genetically engineered immune cells. They are “living drugs” and constitute a milestone in…
Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use
New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…
Genetic variants mimicking IL-6 inhibition linked to lower cardiovascular risk
People with lower interleukin-6 activity have a reduced risk of cardiovascular diseases, a new LMU study reveals. Lowering…
Genetic variants influencing vitamin D synthesis, metabolism, and transport
From skin tone to rare mutations, scientists uncover how your genes influence vitamin D levels, and why standard…
Genetic factors influence obesity risk in children exposed to gestational diabetes
Children exposed to gestational diabetes in utero with a specific variation of a common gene are at a…
GLP1 agonists linked to depression risk in new genetic study
A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between Glucagon-like Peptide-1 (GLP1) receptor agonists-widely…